IM Cannabis Corp. (IMCC)
1.36
+0.03
(+2.26%)
USD |
NASDAQ |
Oct 16, 09:54
IM Cannabis Gross Profit Margin (Quarterly) : 19.83% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.83% |
| March 31, 2026 | 16.35% |
| December 31, 2025 | 0.52% |
| September 30, 2025 | 19.72% |
| June 30, 2025 | 26.98% |
| March 31, 2025 | 27.58% |
| December 31, 2024 | 20.10% |
| September 30, 2024 | 22.68% |
| June 30, 2024 | 5.72% |
| March 31, 2024 | 14.75% |
| December 31, 2023 | 7.86% |
| September 30, 2023 | 21.38% |
| June 30, 2023 | 26.17% |
| Date | Value |
|---|---|
| March 31, 2023 | 23.18% |
| December 31, 2022 | 18.00% |
| September 30, 2022 | 13.78% |
| June 30, 2022 | 17.33% |
| March 31, 2022 | 32.45% |
| December 31, 2021 | 1.36% |
| September 30, 2021 | -6.36% |
| June 30, 2021 | -23.27% |
| March 31, 2021 | 61.92% |
| December 31, 2020 | -149.6% |
| September 30, 2020 | 57.05% |
| June 30, 2020 | 53.90% |
| March 31, 2020 | 47.09% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| InterCure Ltd. | -- |
| Teva Pharmaceutical Industries Ltd. | 52.07% |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 10.90% |
| Purple Biotech Ltd. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -56.13% |
| Return on Invested Capital | -128.4% |
| Profit Margin (Quarterly) | -57.78% |
| Operating Margin (Quarterly) | -27.54% |
| Return on Net Operating Assets | -78.08% |